These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33453304)

  • 21. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of microRNAs in Cholangiocarcinoma.
    Shi T; Morishita A; Kobara H; Masaki T
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies.
    Du X; Zhang J; Wang J; Lin X; Ding F
    Curr Pharm Des; 2018 Feb; 23(39):5997-6010. PubMed ID: 28714414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
    Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
    Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review).
    Lu X; Zhang Y; Xie G; Ding Y; Cong H; Xuan S
    Mol Med Rep; 2020 Nov; 22(5):4091-4100. PubMed ID: 33000279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs as therapeutic targets for lung cancer.
    Cho WC
    Expert Opin Ther Targets; 2010 Oct; 14(10):1005-8. PubMed ID: 20854177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis.
    Soofiyani SR; Hosseini K; Soleimanian A; Abkhooei L; Hoseini AM; Tarhriz V; Ghasemnejad T
    Microrna; 2021; 10(3):181-190. PubMed ID: 34514995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.
    Lo UG; Pong RC; Yang D; Gandee L; Hernandez E; Dang A; Lin CJ; Santoyo J; Ma S; Sonavane R; Huang J; Tseng SF; Moro L; Arbini AA; Kapur P; Raj GV; He D; Lai CH; Lin H; Hsieh JT
    Cancer Res; 2019 Mar; 79(6):1098-1112. PubMed ID: 30504123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of circulating miRNA detection in lung cancer.
    Zhao C; Lu F; Chen H; Zhao F; Zhu Z; Zhao X; Chen H
    Med Oncol; 2016 May; 33(5):41. PubMed ID: 27034265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
    Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MicroRNAs and lung cancer].
    Zamani AG; Zamani A
    Tuberk Toraks; 2013; 61(1):57-62. PubMed ID: 23581269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs: Key Regulators in Lung Cancer.
    El Founini Y; Chaoui I; Dehbi H; El Mzibri M; Abounader R; Guessous F
    Microrna; 2021; 10(2):109-122. PubMed ID: 34047262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
    Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
    Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact.
    Kunz M; Göttlich C; Walles T; Nietzer S; Dandekar G; Dandekar T
    Tumour Biol; 2017 Jul; 39(7):1010428317706430. PubMed ID: 28705115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.